Back
Inventiva SA Vs. Innate Pharma SA Industry Stock Comparison
Sell
42
IVA
Inventiva SA
Last Price:
2.58
Seasonality Move:
18.72%
Sell
33
IPHA
Innate Pharma SA
Last Price:
1.55
Seasonality Move:
8.67%
Sell
42
Inventiva SA (IVA)
is a Sell
Is Inventiva SA a Buy, Sell or Hold?
- The current Inventiva SA [IVA] share price is $2.66. The Score for IVA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- IVA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Innate Pharma SA (IPHA)
is a Sell
Is Innate Pharma SA a Buy, Sell or Hold?
- The current Innate Pharma SA [IPHA] share price is $1.70. The Score for IPHA is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- IPHA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
IVA Stock Price Chart
What is Inventiva SA's stock price today?
-
The Inventiva SA share price today is $2.66
The current trend is moderately bearish and IVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
IPHA Stock Price Chart
What is Innate Pharma SA's stock price today?
-
The Innate Pharma SA share price today is $1.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IPHA is experiencing buying pressure, which is a positive indicator for future bullish movement.
IVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 53.39 | Buy |
| Chaikin Money Flow: | 12389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.64 - 2.76) | Sell |
| Bollinger Bands (100): | (2.07 - 2.69) | Buy |
IPHA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.11 | Sell |
| Relative Strength Index (14 RSI): | 45.45 | Sell |
| Chaikin Money Flow: | 1303 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.64 - 1.94) | Sell |
| Bollinger Bands (100): | (1.89 - 2.29) | Sell |
IVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.7 | Sell |
| 20-day SMA: | 2.71 | Sell |
| 50-day SMA: | 2.37 | Buy |
| 200-day SMA: | 2.94 | Sell |
| 8-day EMA: | 2.7 | Sell |
| 20-day EMA: | 2.65 | Buy |
| 50-day EMA: | 2.51 | Buy |
| 200-day EMA: | 2.88 | Sell |
IPHA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.64 | Buy |
| 20-day SMA: | 1.76 | Sell |
| 50-day SMA: | 1.98 | Sell |
| 200-day SMA: | 2.31 | Sell |
| 8-day EMA: | 1.66 | Buy |
| 20-day EMA: | 1.76 | Sell |
| 50-day EMA: | 1.92 | Sell |
| 200-day EMA: | 2.25 | Sell |
Inventiva SA Earnings Growth & IVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.36 per share.
Innate Pharma SA Earnings Growth & IPHA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.52 per share, and a decrease next year of $0.00 per share.
Inventiva SA Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Innate Pharma SA Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||